Stock analysts at StockNews.com began coverage on shares of LifeVantage (NASDAQ:LFVN – Get Rating) in a research note issued on Saturday. The firm set a "buy" rating on the stock.

LifeVantage Stock Performance

LifeVantage stock opened at $3.86 on Friday. The company has a 50-day simple moving average of $4.24 and a 200-day simple moving average of $4.51. The firm has a market capitalization of $48.45 million, a P/E ratio of 16.08 and a beta of 1.21. LifeVantage has a one year low of $3.70 and a one year high of $7.88.

Institutional Investors Weigh In On LifeVantage

Several institutional investors have recently bought and sold shares of the stock. Victory Capital Management Inc. lifted its holdings in LifeVantage by 39.0% in the fourth quarter. Victory Capital Management Inc. now owns 10,633 shares of the company's stock worth $67,000 after purchasing an additional 2,983 shares during the period. State Street Corp lifted its holdings in LifeVantage by 7.6% in the 1st quarter. State Street Corp now owns 46,191 shares of the company's stock valued at $220,000 after acquiring an additional 3,281 shares during the last quarter. Renaissance Technologies LLC lifted its holdings in LifeVantage by 0.3% in the 2nd quarter. Renaissance Technologies LLC now owns 974,318 shares of the company's stock valued at $4,238,000 after acquiring an additional 3,300 shares during the last quarter. O Shaughnessy Asset Management LLC lifted its holdings in LifeVantage by 49.8% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 23,461 shares of the company's stock valued at $148,000 after acquiring an additional 7,804 shares during the last quarter. Finally, American Century Companies Inc. lifted its holdings in LifeVantage by 38.7% in the 4th quarter. American Century Companies Inc. now owns 35,310 shares of the company's stock valued at $223,000 after acquiring an additional 9,856 shares during the last quarter. Institutional investors and hedge funds own 27.06% of the company's stock.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes.

Featured Articles

• Get a free copy of the StockNews.com research report on LifeVantage (LFVN)
• Could Snap Stock Rebound As Management Restructures?
• MarketBeat: Week in Review 8/29 – 9/2
• Hormel Looks Cheap At These Levels
• Lululemon Set To Soar Into September
• Could Nike Stock be Oversold, but Still Overvalued?

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.